Prudential Financial’s Anavex Life Sciences AVXL Stock Holding History

Prudential Financial’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.3K	Buy	15,155 +2,180	+17%	+$6.45K	﹤0.01%	2445
2026 Q1	$39.8K	Buy	+12,975	New	+$56.2K	﹤0.01%	2340
2025 Q4	–	Sell	-10,535	Closed	-$93.8K	–	2233
2025 Q3	$93.8K	Buy	10,535 +190	+2%	+$1.93K	﹤0.01%	2283
2025 Q2	$95.4K	Buy	+10,345	New	+$88.3K	﹤0.01%	2291
2025 Q1	–	Sell	-10,160	Closed	-$109K	–	2294
2024 Q4	$109K	Buy	+10,160	New	+$78.2K	﹤0.01%	2140
2022 Q4	–	Sell	-37,980	Closed	-$391K	–	2597
2022 Q3	$391K	Buy	+37,980	New	+$401K	﹤0.01%	2183
2022 Q2	–	Sell	-97,780	Closed	-$1.2M	–	2668
2022 Q1	$1.2M	Buy	97,780 +19,900	+26%	+$245K	﹤0.01%	1788
2021 Q4	$1.35M	Buy	+77,880	New	+$1.48M	﹤0.01%	1734

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Prudential Financial's AVXL Position: Q2 2026 in Review

Prudential Financial increased its Anavex Life Sciences (AVXL) stake by 17% in Q2 2026, buying an estimated $6.45K and bringing the position to 15,155 shares worth $39.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2445.

Prudential Financial first reported a position in AVXL in Q4 2021 and has held it in 8 quarters since. The position peaked at $1.35M in Q4 2021. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

Prudential Financial held 15,155 shares of Anavex Life Sciences worth $39.3K as of Q2 2026.
Prudential Financial bought 2,180 Anavex Life Sciences shares in Q2 2026, an estimated $6.45K.
Anavex Life Sciences made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2445 holding.
Prudential Financial first reported a position in Anavex Life Sciences in Q4 2021 and has held it in 8 quarters since.
Prudential Financial's Anavex Life Sciences position peaked at $1.35M in Q4 2021.
179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.